$RGNX: FDA approves most expensive gene therapy ever — and here is its …

Date: Tuesday, May 28th, 2019

Stock(s) mentioned:

Source: Philadelphia Business Journal (https://www.bizjournals.com)

Summary: … president and CEO of Regenxvio (NASDAQ: RGNX). “Its approval demonstrates the transformational impact that NAV Technology can have on the treatment …

Full article address: https://www.bizjournals.com/philadelphia/news/2019/05/28/fda-approves-most-expensive-gene-therapy-ever-and.html

Related News:

$AMGN $SRPT $WING $RGNX $V: Cramer’s lightning round: People doubted this stock, but they’re wrong

$TAC $RGNX: Hedge Funds Have Never Been This Bullish On TransAlta …

$RGNX: Here’s What Hedge Funds Think About Regenxbio Inc (RGNX)

$RGNX: REGENXBIO to Present at the Raymond James 2019 Life Sciences …

$RGNX: REGENXBIO completes dosing in mid-stage wet AMD study

$RGNX: REGENXBIO Announces Completion of Dosing for Phase I/IIa …

$ACOR $RGNX: REGENXBIO (RGNX) Catches Eye: Stock Jumps 7.4%

$RGNX $NVS: REGENXBIO up 5% premarket on FDA nod for gene therapy …

$NVS $RGNX: Approval of a Game-Changing Gene Therapy for SMA Delivers a …

$RGNX: REGENXBIO Announces First FDA Approval of a Gene Therapy …

$RGNX: REGENXBIO to Present at the Bank of America Merrill Lynch 2019 …

Latest News:

$BABA $TCEHY $NTES $ATVI $HUYA $PDD: 5 Takeaways About China’s Tech Landscape from a Stat-Filled Report

$RTN: China warns it will cut ties with any US firm connected to Taiwan arms deal

$MU $DJI $VMW $DELL $MRVL: Cramer Remix: What to make of the inverted yield curve this earnings season

$BMY $LLY $DD $MRVL $GM $KHC: Bristol-Myers Squibb, Eli Lily, DuPont: ‘Mad Money’ Lightning Round

$YOGA: CORRECTING and REPLACING YogaWorks Announces Delisting …

$PLD: Prologis Reports Second Quarter 2019 Earnings Results and …

$HSDT: Glancy Prongay & Murray Reminds Investors of Looming Deadline …

$OMCL: OMCL INVESTIGATION Update: Hagens Berman Updates Omnicell …

$JKS: JinkoSolar Commended for Its High-efficiency Solar Module …

$TWLO: Why Investors Should Want Jeff Immelt on Twilio’s Board

$AMZN $WMT $TGT: Prime Day Isn’t Just For Amazon — Target, Walmart, Others Want a Piece Too